HIV protease inhibitors are a class of antiviral drugs used primarily in the treatment of HIV/AIDS. These inhibitors target the HIV-1 protease enzyme, which is crucial for the viral life cycle. By binding to the active site of the protease, these drugs prevent the enzyme from cleaving precursor proteins into functional viral proteins, thereby inhibiting the maturation of the virus.
